Abstract

Four simple, sensitive, selective and precise methods were developed for the determination of Ornidazole (OZ) in presence of its degradation product. The first method was based on first derivative spectrophotometry D1 and measuring the peak amplitude of D1 spectra at 290.4 and 332 nm. The second method was depended on measuring the peak amplitude of the first derivative of the ratio spectra DD1 at 288.5 and 328 nm. The third method was the mean centering of the ratio spectra one (MCR), which allowed the determination of OZ in presence of its degradate and the concentration of OZ was determined by measuring the amplitude at 312.8 nm. Separation and determination of OZ by HPLC in the forth method was achieved using Lichrosorb RP-18 column and acetonitrile: water, (50:50v/v), 0.2% triethylamine, the pH was adjusted to 4 using o-phosphoric acid. The flow rate was 1 mL min-1. Beer’s law was obeyed in concentration range 5–30 μg/ml for the first three methods. The linearity range in the forth method was 2-20 μg/ml. The proposed methods were used to determine OZ in its pure powdered form with mean percentage recoveries of 99.86 ± 1.249% and 99.98 ± 0.868% for OZ at 290.4 and 332 nm respectively, in D1 method. In DD1 method, the mean percentage recoveries were 100.11 ± 1.020% and 100.15 ± 1.043% at 288.5 and 328 nm respectively. While in MCR and HPLC methods, the mean percentage recoveries were 100.09 ± 0.387% and 100.00 ± 1.302% respectively. The degradation product was obtained in alkaline stress condition, separated, and identified by LC-MS spectral analysis, from which the degradation product was confirmed. The four methods were validated according to International Conference on Harmonization. The four methods were found to be specific for OZ in presence of up to 80% of its degradation product in the first three methods. The four proposed methods were successfully applied for the determination of OZ in Tibezole® tablets. Statistical comparison between the results obtained by these methods and the reported method for the determination of the drug in its pharmaceutical formulation was done, and it was found that there was no significant difference between them.

Highlights

  • It is considered as antibacterial and antiprotozoal

  • Many analytical methods were reported for detection and determination of ornidazole in bulk powder, pharmaceutical formulations alone or in combination with other drugs and/or in Molecular formula=C6H9N3O3; Molecular weight=171.15 Figure 1a: Structure of Orindazole

  • Construction of the calibration graphs for (D1), (DD1), (MCR) and HPLC methods for D1 method: aliquots of OZ working standard solution (0.05 mg mL-1) equivalent to 50-300 μg mL-1 were accurately transferred into a series of 10-mL measuring flasks and the volume was completed to the mark with methanol

Read more

Summary

Introduction

It is considered as antibacterial and antiprotozoal. OZ (Figure 1a) is converted into an active form by reduction of its nitro group, this binds to DNA and prevent nucleic acid formation; it is a bacteriostatic [1,2]. The volumes were completed with methanol to prepare mixtures containing from 10–80% of OZ Deg. Construction of the calibration graphs for (D1), (DD1), (MCR) and HPLC methods for D1 method: aliquots of OZ working standard solution (0.05 mg mL-1) equivalent to 50-300 μg mL-1 were accurately transferred into a series of 10-mL measuring flasks and the volume was completed to the mark with methanol.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.